UPFRONT PEMBROLIZUMAB IN THERAPY OF NIJMEGEN BREAKAGE SY (NBS) PATIENT WITH HODGKIN LYMPHOMA DEMONSTRATED HIGH EFFICACY AND WAS WELL TOLERATED
- Resource Type
- Source
- Leukemia Research. 121:S59
- Subject
Cancer Research Oncology Hematology - Language
- ISSN
- 0145-2126